AAIPharma received certification from Sweden’s Medical Products Agency (MPA) for EU Good Manufacturing Practice (GMP) compliance of its Wilmington, NC operations. The company’s tablet, capsule and other solid dose drug manufacturing and testing operations are now certified as meeting EU GMPs, allowing the Wilmington plant to produce these products for shipment to countries in Europe.        AAIPharma’s sterile manufacturing operations in Charleston, SC also passed an FDA inspection and ...